Primary Brain Tumors Are Enriched for CXCR3+ T Cells and Treatment of Human Glioma Cell Lines With GSK126 Reverses Histone Methylation Leading to Increased T Cell Chemoattraction. This evidence concerns the gene CXCR3 and central nervous system cancer.